Rethinking pharma: Production flexibility as a strategic decision
A pharmaceutical start-up responds to real shortages on the market — with flexible production, clear leadership and a focus on supply security in Europe.
In pharmaceutical production, it is becoming increasingly apparent that existing structures are not suited to all requirements, particularly when flexibility is needed. Complex Pharmaceuticals was founded at the end of 2024 to close precisely this gap. Especially in the area of rare therapies, it is often difficult to have small batches manufactured in a timely manner. Classical production models are designed for high unit numbers, not for variability.